“The Venetoclax Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient With COVID : VEN AZA Effectively Targets AML Clones”. 2022. Mediterranean Journal of Hematology and Infectious Diseases 14 (1): e2022041. https://doi.org/10.4084/MJHID.2022.041.